Catalent, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
03 Januar 2022 - 10:15PM
Business Wire
Catalent, the leading global provider of advanced delivery
technologies, development, manufacturing and clinical supply
solutions for drugs, biologics, cell and gene therapies, as well as
consumer health products, today announced that members of its
executive leadership team will virtually present at the 40th Annual
J.P. Morgan Healthcare Conference at 7:30 a.m. ET on January 10,
2022.
A live webcast of the presentation will be accessible at
http://investor.catalent.com and will be available for replay
following the event.
About Catalent, Inc.
Catalent, Inc. (NYSE: CTLT), an S&P 500® company, is the
global leader in enabling pharma, biotech, and consumer health
partners to optimize product development, launch, and full
life-cycle supply for patients around the world. With broad and
deep scale and expertise in development sciences, delivery
technologies, and multi-modality manufacturing, Catalent is the
industry’s preferred partner for personalized medicines, consumer
health brand extensions, and blockbuster drugs. Catalent helps
accelerate over 1,000 partner programs and launch over 150 new
products every year. Its flexible manufacturing platforms at over
50 global sites supply over 70 billion doses of nearly 7,000
products to over 1,000 customers annually. Catalent’s expert
workforce exceeds 17,000, including more than 2,500 scientists and
technicians. Headquartered in Somerset, New Jersey, the company
generated $4 billion in revenue in its 2021 fiscal year. For more
information, visit www.catalent.com.
More products. Better treatments. Reliably supplied.™
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220103005413/en/
Investor Contact: Paul Surdez, Catalent, Inc. (732) 537-6325
investors@catalent.com
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Jul 2024 bis Aug 2024
Catalent (NYSE:CTLT)
Historical Stock Chart
Von Aug 2023 bis Aug 2024